ENGERIX-B (Dispensing Solutions Inc.)


Welcome to the PulseAid listing for the ENGERIX-B drug offered from Dispensing Solutions Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dispensing Solutions Inc.
NON-PROPRIETARY NAME: Hepatitis B Vaccine (Recombinant)
SUBSTANCE NAME: HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-05-28
END MARKETING DATE: 0000-00-00


ENGERIX-B HUMAN PRESCRIPTION DRUG Details:

Item DescriptionENGERIX-B from Dispensing Solutions Inc.
LABELER NAME: Dispensing Solutions Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(ug/mL)
START MARKETING DATE: 2009-05-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68258-3042_f11aa988-f958-4f75-ab9b-89c24998faff
PRODUCT NDC: 68258-3042
APPLICATION NUMBER: BLA103239

Other HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions Inc.ENGERIX-B
GlaxoSmithKline Biologicals SAENGERIX-B